Dr. Reddy's Laboratories
Sushrut Kulkarni serves as the Global Head of IPDO at Dr. Reddy's Laboratories since May 2022. Prior to this role, Sushrut held several key positions at Glenmark Pharmaceuticals Ltd., including Executive Vice President & Head Global Pharmaceutical Development and Group Vice President for Formulation & CMC. Additionally, Sushrut was the Senior Vice President of US Generics at Zydus Cadila and has held various senior roles at Glenmark Generics Ltd. and Zydus Cadila over a span of several years. Early career experience includes positions at Torrent Research Centre and Sandoz INDIA. Sushrut holds an M Pharm in Pharmaceutical Chemistry from Bombay College of Pharmacy and a B Pharm in Pharmaceutics from Shivaji University, along with a secondary school education from Vidyapeeth High School.
This person is not in any teams
This person is not in any offices
Dr. Reddy's Laboratories
68 followers
Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Their major markets include – USA, India, Russia & CIS countries, and Europe.